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Abstract:  Nutritional  fatty  acids  are  known  to  have  an  impact  on  membrane  lipid 
composition of body cells, including cells of the immune system, thus providing a link 
between dietary fatty acid uptake, inflammation and immunity. In this study we reveal the 
significance of macrophage membrane lipid composition on gene expression and cytokine 
synthesis thereby highlighting signal transduction processes, macrophage activation as well 
as macrophage defense mechanisms. Using RAW264.7 macrophages as a model system, 
we identified polyunsaturated fatty acids (PUFA) of both the n-3 and the n-6 family to 
down-regulate the synthesis of: (i) the pro-inflammatory cytokines IL-1β, IL-6 and TNF-α; 
(ii)  the  co-stimulatory  molecule  CD86;  as  well  as  (iii)  the  antimicrobial  polypeptide 
lysozyme. The action of the fatty acids partially depended on the activation status of the 
macrophages. It is particularly important to note that the anti-inflammatory action of the 
PUFA could also be seen in case of infection of RAW264.7 with viable microorganisms of 
the genera R. equi and P. aeruginosa. In summary, our data provide strong evidence that 
PUFA  from  both  the  n-3  and  the  n-6  family  down-regulate  inflammation  processes  in 
context of chronic infections caused by persistent pathogens. 
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1. Introduction 
Fatty  acids  are  an  integral  part  of  cellular  membranes.  The  heterogeneity  of  fatty  acids  in  the 
membrane contributes to membrane fluidity as well as to the physical and chemical properties of various 
membrane  domains  [1,2].  In  fact,  basic  properties  of  membranes  as  fatty  acid  chain  order,  phase 
behavior, elastic compressibility, ion permeability, fusion, rapid flip-flop as well as protein function 
are known to be determined by the lipid composition [1–3]. Accordingly, numerous cellular functions 
critically rely on the dynamic characteristics of the membranes. This includes cell signaling mechanisms 
as well as catalytic processes by membrane-associated enzymes [1,2]. Of note, nutritional fatty acids 
are known to have an impact on membrane lipid composition of body cells, including cells of the immune 
system [4–7]. Thus, there is a link between dietary fatty acid uptake, inflammation and immunity. 
Infectious diseases occur when a microorganism succeeds in overwhelming innate host defenses. 
Macrophages play a key role in innate immunity due to their ability to detect and destroy pathogens 
without the help of an adaptive immune response [8,9]. The antigen-presenting scavenger cells serve 
as a source of  cytokines like  IL-1β,  IL-6,  IL-10 and TNF-α,  and are  crucial for orchestrating the 
immune response [10,11]. Evading the macrophage defense mechanisms therefore is a precondition for 
microorganisms to establish a local site of infection, to replicate and to successfully disseminate within 
the host. Immunocompromised individuals are in special danger of developing serious infections with 
Rhodococcus equi and Pseudomonas aeruginosa [12–14]. 
R. equi, a Gram-positive, aerobic, facultative intracellular and immotile soil bacterium, is known as 
a  pulmonary  pathogen  of  young  horses  and  immunocompromised  humans,  such  as  AIDS  
patients  [13–15].  There  are  both  virulent  and  non-virulent  isolates.  The  infectivity  depends  on  
the presence of distinct virulence-associated proteins and plasmids. The pathogen has been shown to 
survive  and  to  multiply  in  macrophages  via  arresting  the  normal  pathway  of  phagosome  
maturation [16,17]. Once internalized R. equi prevents the fusion of its phagosome with lysosomes 
thus leading to an arrested phagosome neutral in pH and without any lysosomal contents [16,17]. In 
this way R. equi is able to establish a niche for survival inside the host cell [17].  
P. aeruginosa, a Gram-negative, facultative anaerobic bacterium with unipolar motility, is known as 
a nosocomial pathogen of immunocompromised individuals [18]. Tissues typically infected are the 
pulmonary tract, urinary tract, burns and wounds [12]. Moreover, P. aeruginosa is reported to be the 
most frequent colonizer of medical devices (e.g., catheters) [12]. Infections with P. aeruginosa are 
often difficult to treat [19]. The pathogen has been demonstrated to exhibit numerous enzymatic and 
mutational mechanisms of bacterial resistance [19,20]. Environmental persistence is further increased 
by  the  ability  of  P.  aeruginosa  to  form  biofilms  [21].  In  addition,  the  microorganism  has  been  
reported to synchronize gene expression by an intercellular communication mechanism, the quorum 
sensing [21,22]. This mechanism enables the bacterial population to act as a single organism and to Int. J. Mol. Sci. 2011, 12                       
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modulate a number of  virulence  factors, including biofilm formation  as well as the production of 
numerous toxins [21,22]. 
Feeding studies concerning the impact of PUFA supplementation on immune defense mechanisms 
yielded conflicting findings, so far. This is aggravated by variations in experimental settings leading to 
a lack in comparability of gained results. Moreover, virtually no data regarding the relevance of PUFA 
in case of macrophage infection with R. equi or P. aeruginosa exist. Hence, in this in vitro-study under 
defined  conditions,  we  reveal  the  implication  of  stimulation  and  PUFA  supplementation  on  key 
proteins of innate immune response. 
2. Results and Discussion 
2.1. Cytokines 
Cytokines  play  a  pivotal  role  in  intercellular  communication  acting  as  immune-modulating.  In 
particular, macrophages are potent producers of the small cell-signaling protein molecules including 
the pro-inflammatory IL-1β, IL-6 and TNF-α as well as the anti-inflammatory IL-10. The mediator 
molecules are a crucial component of host defense. However, pro-inflammatory cytokines also are held 
responsible for the destruction of host tissue [23]. 
Stimulation of RAW264.7 with lipopolysaccharide (LPS), phorbol-12-myristate-13-acetate (PMA), 
P. aeruginosa and R. equi respectively induced an increase in the concentration of pro-inflammatory 
cytokines in cell supernatants (Figure 1). Significant differences depending on the stimulator added 
could be assessed. Treatment of the cells with LPS resulted in a significant increase in the concentration 
of IL-1β, IL-6 as well as TNF-α (Figure 1). In contrast, after stimulation of the macrophages with PMA 
a  significant  increase  could  only  be  seen  for  TNF-α  (Figure  1).  Addition  of  the  quorum  sensing 
molecule N3-oxododecanoyl-L-homoserine lactone (OdDHL) to the culture medium did not affect the 
concentration of pro-inflammatory cytokines in cell supernatants (Figure 1). The combination of LPS 
and OdDHL abrogated the stimulating effect of LPS on IL-1β, IL-6 and TNF-α synthesis (Figure 1). 
Culturing of RAW264.7 in presence of the viable pathogens P. aeruginosa and R. equi boosted pro-
inflammatory cytokine synthesis as well (Figure 1). The virulent strain R. equi ATCC 33701 was 
found to act more effectively in increasing the production of IL-1β, IL-6 and TNF-α by the macrophages 
than the non-virulent strain R. equi ATCC 6939 (Figure 1). 
Enrichment  of  the  culture  medium  with  fatty  acids  diminished  the  stimulatory  effects  of  LPS,  
P. aeruginosa and R. equi. Concentration of IL-1β in supernatants of RAW264.7 stimulated with LPS 
or  P.  aeruginosa  was  decreased  significantly  following  feeding  of  cells  with  the  n-3  PUFA  
alpha-linolenic acid (LNA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) as well as 
the  n-6  PUFA  linoleic  acid  (LA)  and  arachidonic  acid  (AA)  (Figure  2).  In  context  of  
R. equi-stimulation a significant reduction in IL-1β concentration could only be seen for macrophages 
supplemented with DHA and LA regardless the R. equi-strain tested (Figure 2). Concentration of IL-6 
in supernatants of RAW264.7 was decreased significantly following feeding of cells with DHA, LA or 
AA  for  LPS  stimulation  as  well  as  following  feeding  of  cells  with  LNA,  EPA,  DHA  or  LA  for 
stimulation with P. aeruginosa (Figure 3). For RAW264.7 stimulated with R. equi ATCC 6939 or  
R. equi ATCC 33701 no effect of PUFA supplementation on IL-6 production was seen (Figure 3). Int. J. Mol. Sci. 2011, 12                       
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PUFA that had a decreasing effect on the secretion of TNF-α by the macrophages were LNA, EPA and 
DHA for LPS stimulated cells, LNA, EPA, DHA and LA for cells treated with P. aeruginosa, LA for 
cells treated with the non-virulent strain R. equi ATCC 6939 as well as LNA, EPA, DHA, LA and AA 
for cells treated with the virulent strain R. equi ATCC 33701 (Figure 4). For un-stimulated cells as well 
as  for  cells  treated  with  PMA  no  effects  of  PUFA  supplementation  on  the  production  of  the  
pro-inflammatory  cytokines  IL-1β,  IL-6  and  TNF-α  could  be  seen  (data  not  shown).  Furthermore, 
treatment of the cells with LPS in combination with the quorum sensing molecule OdDHL abolished 
the PUFA effects observed for LPS stimulated RAW264.7 (data not shown). 
Figure  1.  Concentration  of  IL-1β,  IL-6  and  TNF-α  in  supernatants  of  RAW264.7 
macrophages,  cultured  in  basic  medium  after  24  h  of  stimulation  with  
lipopolysaccharide  (LPS),  N-(3-oxododecanoyl)-L-homoserine  lactone  (OdDHL),  
LPS  +  OdDHL,  phorbol-12-myristate-13-acetate  (PMA),  P.  aeruginosa  ATCC  10145,  
R. equi ATCC 6939 and R. equi ATCC 33701 respectively. Data are mean ± SD (n = 6). 
Bars denoted by different letters are significantly different. 
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Figure 2. Concentration of IL-1β in supernatants of RAW264.7 macrophages cultured in 
basic medium as well as in medium supplemented with 15 µmol/L alpha-linolenic acid (LNA), 
eicosapentaenoic  acid  (EPA),  docosahexaenoic  acid  (DHA),  linoleic  acid  (LA)  or 
arachidonic acid (AA) after 24 h of stimulation with LPS, P. aeruginosa ATCC 10145,  
R. equi ATCC 6939 and R. equi ATCC 33701 respectively. Data are mean ± SD (n = 6). 
Bars denoted by different letters are significantly different. 
 
Figure 3. Concentration of IL-6 in supernatants of RAW264.7 macrophages cultured in 
basic medium as well as in medium supplemented with 15 µmol/L alpha-linolenic acid (LNA), 
eicosapentaenoic  acid  (EPA),  docosahexaenoic  acid  (DHA),  linoleic  acid  (LA)  or 
arachidonic acid (AA) after 24 h of stimulation with LPS, P. aeruginosa ATCC 10145,  
R. equi ATCC 6939 and R. equi ATCC 33701 respectively. Data are mean ± SD (n = 6). 
Bars denoted by different letters are significantly different. 
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Figure 3. Cont.  
 
Figure 4. Concentration of TNF-α in supernatants of RAW264.7 macrophages cultured in 
basic medium as well as in medium supplemented with 15 µmol/L alpha-linolenic acid (LNA), 
eicosapentaenoic  acid  (EPA),  docosahexaenoic  acid  (DHA),  linoleic  acid  (LA)  or 
arachidonic acid (AA) after 24 h of stimulation with LPS, P. aeruginosa ATCC 10145,  
R. equi ATCC 6939 and R. equi ATCC 33701 respectively. Data are mean ± SD (n = 6). 
Bars denoted by different letters are significantly different. 
 
 
Synthesis of the anti-inflammatory cytokine IL-10 was not significantly affected by stimulation of 
RAW264.7  with  LPS,  PMA,  P.  aeruginosa  and  R.  equi  respectively  (Figure  5).  Likewise, 
supplementation of the macrophages with the n-3 PUFA LNA and EPA or the n-6 PUFA LA and AA Int. J. Mol. Sci. 2011, 12                       
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did not result in any changes in IL-10 concentration in cell supernatants both for un-stimulated as well 
as  for  stimulated  cells  (data  not  shown).  Enrichment  of  the  culture  medium  with  DHA,  however, 
brought about a significant increase in IL-10 production and secretion of RAW264.7 stimulated with 
LPS,  P.  aeruginosa  and  R.  equi  respectively  (Figure  5).  Treatment  of  the  cells  with  LPS  in 
combination with OdDHL abolished this effect (Figure 5). 
Figure 5. Concentration of IL-10 in supernatants of RAW264.7 macrophages cultured in 
basic medium as well as in medium supplemented with 15 µmol/L docosahexaenoic acid (DHA) 
after 24 h of stimulation with LPS, PMA, P. aeruginosa ATCC 10145, R. equi ATCC 6939 
and R. equi ATCC 33701 respectively. Data are mean ± SD (n = 6). Bars denoted by 
different letters are significantly different. 
 
In  summary,  our  data  underline  the  interaction  of  PUFA  and  cytokine  production  by  activated 
macrophages.  The  results  presented  here  demonstrate  the  fatty  acids  to  arrest  the  secretion  of  
pro-inflammatory cytokines and, moreover, for DHA to promote the production of an anti-inflammatory 
cytokine. So far, the inhibitory effect of unsaturated fatty acids on macrophage synthesis of IL-1β, IL-6 
and TNF-α has solely been shown for the n-3 PUFA EPA and DHA [24,25]. Likewise, to our best 
knowledge,  the  effects  of  PUFA  supplementations  on  macrophage  IL-10  synthesis  has  solely 
elucidated for these two n-3 fatty acids [26]. Thus, our results extend the current knowledge providing 
evidence that PUFA of both the n-3 and the n-6 family drive macrophage immune response into an 
anti-inflammatory direction. Of note, the immune suppressing effect of the fatty acids tested could be 
seen for adequately stimulated macrophages only. This indicates that the PUFA may interfere with 
intracellular  signal  transduction  processes  related  with  macrophage  activation  thus  resulting  in  an 
inhibited up-regulation of cytokine synthesis. 
Macrophages respond to a variety of pathogen-associated molecular patterns (PAMPs) by means of 
a  wide  repertoire  of  distinct  pattern  recognition  receptors  (PRRs).  LPS  is  recognized  by  Toll-like 
receptor 4 (TLR4) [27,28]. The viable pathogens R. equi and P. aeruginosa, which are characterized 
by  multiple  pathogen-specific  PAMPs,  are  sensed  by  several  TLRs  including  TLR2,  TLR4  and  
TLR5 [23,27–29]. Following ligand binding TLRs are reported to dimerize and to be recruited into 
lipid rafts, where they interact with downstream adaptor molecules [30,31]. Data from our previous 
studies demonstrate that supplementation of immune cells with PUFA results in an incorporation of the Int. J. Mol. Sci. 2011, 12                       
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fatty acids into cellular membranes, which is accompanied with a modulation of lipid composition in 
membrane rafts [31]. In fact, inhibition of lipid raft formation by PUFA has already been shown to 
reduce the recruitment of signaling molecules, such as TLR4, into the rafts [30,31]. PUFA enrichment 
in membrane rafts therefore seems to be a feasible mechanism of action of the fatty acid-mediated 
suppression of cytokine synthesis up-regulation by stimulated macrophages. 
2.2. Surface Molecules 
Beside  cytokines  macrophages  also  communicate  with  other  cells  of  the  immune  system  by  
means of several distinct surface molecules such as the major histocompatibility complex II (MHCII) 
and the CD antigen 86. MHC class II molecules present antigenic peptides generated in intracellular 
vesicles of the macrophage to T helper cells. The interaction of a specific peptide:MHC complex with 
the T cell receptor activates the naive T cell. However, a second signal, maintained via interaction of 
the co-stimulatory molecule CD86 with CD28, is needed to stimulate the clonal expansion of naive  
T  cells.  A  further  surface  molecule  expressed  by  macrophages  is  the  Fc  receptor.  Fc  receptors 
recognize  the  Fc  portion  of  immunoglobulins.  Ligand  binding  results  in  an  activation  of  the 
macrophage, which is characterized by an increase in the rate of phagocytosis as well as an increase in 
its bactericidal activity. 
Stimulation of RAW264.7 with LPS, PMA, R. equi and P. aeruginosa respectively resulted in a 
down-regulation of the MHCII gene expression (Figure 6). For LPS, PMA and P. aeruginosa the 
expression level dropped to a tenth compared to untreated cells (Figure 6). For R. equi the abrogating 
action was less pronounced (Figure 6). No effect of PUFA supplementation on MHCII gene expression 
could be seen neither for un-stimulated nor for stimulated cells (data not shown). 
The expression of the Fc receptor gene was up-regulated by 1.5 to 2 fold following treatment of 
RAW264.7 with LPS, PMA, R. equi and P. aeruginosa respectively (Figure 6). There was no effect of 
PUFA supplementation of cells on the expression level of the Fc receptor gene both for un-stimulated 
as well as for stimulated RAW264.7 (data not shown). 
Figure  6.  Expression  of  the  MHCII  and  the  Fc  receptor  mRNA  by  RAW264.7 
macrophages  cultured  in  basic  medium  after  24  h  of  stimulation  with  LPS,  PMA,  
P. aeruginosa ATCC 10145 and R. equi ATCC 33701 respectively. Data are mean ± SD  
(n = 6). Bars denoted by different letters are significantly different. 
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Expression of the CD86 gene increased due to the stimulation of RAW264.7 with LPS, PMA,  
R.  equi  and  P.aeruginosa  respectively  (Figure  7).  In  the  case  of  PMA  and  R.  equi  this  could  be 
impaired by enrichment of the cells with PUFA. For R. equi the fatty acid supplementation completely 
abrogated the up-regulating effect (Figure 7). Fatty acids identified to act most effective were the  
n-3 PUFA LNA as well as the n-6 PUFA LA (Figure 7). Regarding RAW264.7 treated with LPS or  
P. aeruginosa there was no diminishing action of the PUFA added (Figure 7). Likewise, for un-stimulated 
RAW264.7 no impairment of CD86 gene expression could be seen (data not shown). 
Figure 7. Expression of the CD86 mRNA by RAW264.7 macrophages cultured in basic 
medium as well as in medium supplemented with 15 µmol/L alpha-linolenic acid (LNA), 
eicosapentaenoic  acid  (EPA),  docosahexaenoic  acid  (DHA),  linoleic  acid  (LA)  or 
arachidonic acid (AA) after 24 h of stimulation with LPS, PMA, P. aeruginosa ATCC 10145 
and R. equi ATCC 33701 respectively. Data are mean ± SD (n = 6). Bars denoted by 
different letters are significantly different. 
 
 
Flow cytometric analyses confirmed the abrogating effect of a fatty acid enrichment of RAW264.7 
on CD86 protein expression. As seen in the gene expression analysis, the diminishing action of the 
PUFA  supplemented  was  especially  apparent  for  RAW264.7  stimulated  with  PMA  and  R.  equi 
respectively (Figure 8). Here, too, the n-3 PUFA LNA and the n-6 PUFA LA were most effective (Figure 8). 
However, a moderate reduction in CD86 positive cells due to PUFA supplementation could also be 
seen for RAW264.7 treated with LPS or P. aeruginosa as well as for un-stimulated cells (Figure 8). Int. J. Mol. Sci. 2011, 12                       
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Figure 8. Expression of the surface molecule CD86 by RAW264.7 macrophages cultured 
in basic medium as well as in medium supplemented with 15 µmol/L alpha-linolenic acid (LNA), 
eicosapentaenoic  acid  (EPA),  docosahexaenoic  acid  (DHA),  linoleic  acid  (LA)  or 
arachidonic acid (AA) after 24 h of stimulation with LPS, PMA, P. aeruginosa ATCC 10145 
and R. equi ATCC 33701 respectively. (A) Percentage of CD86 positive cells. Data are 
mean  ±  SD  (n  =  6).  Bars  denoted  by  different  letters  are  significantly  different; 
(B) Histograms  of  surface  expression  levels  of  CD86.  The  grey-shaded  histograms 
correspond to RAW264.7 cultured in basic medium, and empty histograms (dark grey line) 
correspond  to  RAW264.7  cultured  in  LNA  supplemented  medium.  Histograms  are 
representative of one of six experiments. 
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Figure 8. Cont.  
 
Taking  together,  our  data  demonstrate  PUFA  to  modulate  the  expression  of  the  co-stimulatory 
molecule CD86 but not of the MHC class II molecules or the Fc receptor. The diminishing action of 
unsaturated fatty acids on CD86 expression could be shown for all PUFA tested, in particular LNA and 
LA. Hence, our data provide first evidence that fatty acids from both the n-3 and the n-6 family reduce 
the expression levels of CD86. Of note, the down-regulation of CD86 was demonstrated not only on 
mRNA level but also on protein level thus underlining the relevance of gained results. Interestingly, on 
protein level the abrogating effect of the fatty  acids added could be seen for both stimulated and  
un-stimulated RAW264.7. This suggests that there are two independent mechanisms of action. On the 
one  hand  PUFA  supplementation  of  cells  might  modulate  membrane  raft  lipid  composition  thus 
interfering with a stimulator-mediated activation of the macrophages, as already discussed. On the 
other hand PUFA are reported to regulate gene expression via interaction with nuclear and G protein 
coupled receptors [26,32]. The interaction of the fatty acids with the peroxisome proliferator-activated 
receptors (PPARs) [33] as well as with the G protein coupled receptor 120 (GPR120) was found to 
mediate anti-inflammatory effects, particularly in macrophages [32]. 
2.3. Adapter Proteins 
Activation of macrophages by PAMPs crucially depends on intracellular adapter proteins, which  
are  accessory  to  key  proteins  in  signal  transduction  pathways.  The  universal  adaptor  protein  used  
by TLRs is the myeloid differentiation primary response gene 88 (MyD88) [27,28]. Microbial products 
in  the  cytoplasm  of  the  cell  are  sensed  by  the  Nod-like  receptors  Nod1  and  Nod2  [27,28].  The Int. J. Mol. Sci. 2011, 12                       
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receptor-interacting protein-like interacting caspase-like apoptosis regulatory protein kinase (RICK) 
functions as the adaptor protein downstream of Nod1 and Nod2 [27,28]. Both, MyD88 and RICK, 
mediate  NFκB  and  mitogen-activated  protein  kinase  (MAPK)  activation  in  response  to  specific 
pathogenic stimuli [27,28]. 
Treatment of RAW264.7 with LPS, PMA, R. equi and P. aeruginosa respectively did not affect the 
expression of the MyD88 gene (Figure 9). However, there was a moderate but not significant decrease 
in MyD88 expression level following enrichment of stimulated cells with PUFA (data not shown). 
This effect was independent of the kind of stimulator used. 
Figure 9. Expression of the MyD88 and the RICK mRNA by RAW264.7 macrophages 
cultured in basic medium after 24 h of stimulation with LPS, PMA, P. aeruginosa ATCC 10145 
and R. equi ATCC 33701 respectively. Data are mean ± SD (n = 6). Bars denoted by 
different letters are significantly different. 
 
Expression of the RICK gene was up-regulated by stimulation of RAW264.7 with LPS, R. equi or  
P. aeruginosa (Figure 9). Treatment of the cells with PMA, in contrast, did not result in any changes in 
RICK expression level (Figure 9). Enrichment of culture medium with PUFA revealed the fatty acids 
not  to  affect  the  gene  expression  of  RICK.  No  effect  of  PUFA  supplementation  of  cells  on  the 
expression level of the RICK gene could be seen either for un-stimulated or for stimulated RAW264.7 
(data not shown). 
Overall,  our  results  support  the  assumption  that  the  molecular  targets  of  PUFA  are  signaling 
components upstream of the adaptor proteins MyD88 and RICK. This is in accordance with previous 
data reporting that the suppression of NFκB by DHA is not mediated by MyD88 [33]. 
2.4. Lysozyme 
Lysozyme, a predominant antimicrobial polypeptide, is present in macrophages in high concentrations. 
The  enzyme  exerts  bacteriolytic  effects  due  to  its  peptidoglycane-hydrolyzing  activity  [34]. 
Peptidoglycane  degradation  by  lysozyme  results  in  a  perturbation  of  the  bacterial  cell  wall,  and, 
therefore, in the inability of the microorganism to withstand osmotic pressure. Lysozyme can be found Int. J. Mol. Sci. 2011, 12                       
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in  the  lysosomes  of  macrophages,  but  can  also  be  released  in  the  environment  when  the  cells 
degranulate providing a first line in innate immune defense [35]. 
Treatment  of  RAW264.7  with  LPS,  PMA,  R.  equi  and  P.  aeruginosa  resulted  in  a  marked  
down-regulation  of  the  lysozyme  gene  (Figure  10).  The  expression  level  dropped  by  one  to  
two  third  (Figure  10).  Supplementation  of  the  cells  with  PUFA  further  decreased  lysozyme  gene 
expression (Figure 10). The impairment of the lysozyme gene expression by the fatty acids could be 
seen for all stimuli tested as well as for un-stimulated RAW264.7 (Figure 10). 
Figure 10. Expression of the lysozyme mRNA by RAW264.7 macrophages cultured in 
basic medium as well as in medium supplemented with 15 µmol/L alpha-linolenic acid (LNA), 
eicosapentaenoic  acid  (EPA),  docosahexaenoic  acid  (DHA),  linoleic  acid  (LA)  or 
arachidonic acid (AA) after 24 h of stimulation with LPS, PMA, P. aeruginosa ATCC 10145 
and R. equi ATCC 33701 respectively. Data are mean ± SD (n = 6). Bars denoted by 
different letters are significantly different. 
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Figure 10. Cont.  
 
Determination of total lysozyme activity confirmed the diminishing effect of the fatty acids. As seen 
in  the  gene  expression  analysis,  the  abrogating  action  of  the  PUFA  added  emerged  both  for  
un-stimulated (Figure 11) and stimulated cells (data not shown). 
Figure  11.  Total  enzyme  activity  of  lysozyme  of  RAW264.7  macrophages  cultured  in 
basic medium as well as in medium supplemented with 15 µmol/L alpha-linolenic acid (LNA), 
eicosapentaenoic  acid  (EPA),  docosahexaenoic  acid  (DHA),  linoleic  acid  (LA)  or 
arachidonic acid (AA). Data are mean ± SD (n = 6). Bars denoted by different letters are 
significantly different. 
 
Summing  up,  our  data  clearly  demonstrate  PUFA  to  down-regulate  lysozyme  gene  expression 
resulting in a decrease in enzyme activity. To our knowledge, this is the first time that unsaturated fatty 
acids were shown to affect lysozyme synthesis. Here, too, however, the immune-suppressive effect of 
PUFA from both the n-3 and the n-6 family becomes apparent. 
3. Experimental Section 
3.1. Materials 
All  chemicals  and  reagents  were  obtained  from  Sigma-Aldrich  (Taufkirchen,  Germany)  unless 
noted otherwise. Cell culture flasks were purchased from Greiner Bio-One (Frickenhausen, Germany). Int. J. Mol. Sci. 2011, 12                       
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HEPES  (25  mmol/L)-buffered  RPMI  1640  culture  medium  containing  300  mg/L  L-glutamine  was 
acquired from PAA Laboratories GmbH (Cölbe, Germany). 
3.2. Cell Culture 
The permanent mouse monocyte/macrophage cell line RAW264.7 (ATCC: TIB-71) was used. The 
RAW264.7  cells  were  cultured  in  RPMI  1640  medium  supplemented  with  4.5  g/L  glucose  and  
5% FCS (basic medium). The fatty acids alpha-linolenic acid (LNA), eicosapentaenoic acid (EPA), 
docosahexaenoic  acid  (DHA),  linoleic  acid  (LA)  or  arachidonic  acid  (AA)  (all  Biotrend,  Köln, 
Germany) were included in the culture medium in concentrations of 15 µmol/L using ethanol as a 
vehicle (0.2% v/v final ethanol concentration). Cells were incubated in 75 cm
2 cell culture flasks at a 
density of 1 × 10
6 cells/mL for 72 h at 37 °C and 5% CO2 in a humidified atmosphere. Stimulation of 
cells  was  performed  for  24  h  by  means  of  LPS  (1  µg/mL,  from  E.  coli  serotype  0111:B4),  
PMA (1 µM), R. equi (ATCC: 33701/6939, viable, MOI 0.1), P. aeruginosa (ATCC 10145, viable, 
growth restriction via gentamicin (10 µg/mL), MOI 1), N-(3-oxododecanoyl)-L-homoserine lactone 
(OdDHL, 5 µM) or a combination of LPS (1 µg/mL, from E. coli serotype 0111:B4) plus OdDHL (5 µM). 
3.3. Cytokine Production 
RAW264.7 were seeded and stimulated with LPS, OdDHL, LPS + OdDHL, PMA, P. aeruginosa 
ATCC 10145, R. equi ATCC 33701 and R. equi ATCC 6939 respectively as described above. IL-1β, 
IL-6, IL-10 and TNF-α were detected in supernatants using murine ELISA kits (Preprotech, London, UK) 
according to the manufacturer’s instructions. Absorbance was read on a SpectraMax 340PC ELISA 
reader at 450 nm and analysis done using SoftMax Pro 5 software (all Molecular Device, Munich, 
Germany). Analysis was performed in triplicates in 6 independent experiments for each combination 
of fatty acid supplementation and stimulator. 
3.4. Gene Expression Analysis 
RAW264.7 were seeded and stimulated with LPS, PMA, P. aeruginosa ATCC 10145 and R. equi 
ATCC 33701 respectively as described above. Gene expression was analyzed by means of a SYBR 
Green-based quantitative real-time PCR technology. Total RNA was extracted utilizing the RNeasy kit 
(Qiagen GmbH, Hilden, Germany). Complementary DNA was synthesized using the Oligo(dT)12–18Primer 
and the SuperScript
® III Reverse Transcriptase from Invitrogen (Darmstadt, Germany). Quantitative 
PCR was performed in duplicates using suitable murine RT
2 qPCR primer assays (SABiosciences, 
Frederick, USA) and the SensiMix
TM SYBR Kit (Bioline, Luckenwalde, Germany). Genes of interest 
amplified are MYD88, RIPK2, H2-AA, CD86, FCGR2B and LYZ2; housekeeping genes amplified are 
HPRT and CASC3. Positive controls by means of the XpressRef
TM Universal Total RNA (SABiosciences, 
Frederick, USA) as well as negative controls (i.e., no template control) were prepared for every run. 
Thermal cycling was carried out on a Rotor-Gene 6000 real time PCR system (Qiagen GmbH, Hilden, 
Germany) starting with one cycle at 95 °C for 10 min followed by 45 cycles of 95 °C for 15 s, 55 °C 
for 30 s and 72 °C for 15 s. Relative quantification studies were performed with the Rotor-Gene 6000 
Series Software 1.7. The entire procedure was replicated for 3 times on independent RNA isolations. Int. J. Mol. Sci. 2011, 12                       
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3.5. Lysozyme Assay 
RAW264.7  were  seeded  and  stimulated  with  LPS,  PMA,  P.  aeruginosa  ATCC  10145  and  
R. equi ATCC 33701 respectively as described above. Total enzyme activity of lysozyme was detected 
in cell supernatants as well as cell lysates obtained by sonification using the EnzChek
® Lysozyme 
assay kit (Invitrogen, Darmstadt, Germany) according to the manufacturer`s instructions. Fluorescence 
was  read  on  a  SpectraMax  340PC  ELISA  reader  at  an  excitation  wavelength  of  485  nm  and  an 
emission  wavelength  of  535  nm,  and  analysis  done  using  SoftMax  Pro  5  software  (all  Molecular 
Device, Munich, Germany). Analysis was performed in triplicates in 2 independent experiments for 
each combination of fatty acid supplementation and stimulator. 
3.6. CD86 Protein Expression 
RAW264.7  were  seeded  and  stimulated  with  LPS,  PMA,  P.  aeruginosa  ATCC  10145  and  
R.  equi  ATCC  33701  respectively  as  described  above.  Cells  were  stained  for  the  surface  marker  
anti-CD86 PE (Miltenyi Biotec GmbH, Bergisch Gladbach, Germany) and fixed in 1% formaldehyde 
in PBS. In all cases a Fc block (purified anti mouse CD16/CD32) (Miltenyi Biotec GmbH, Bergisch 
Gladbach, Germany) was used. Specifity of staining was verified via isotope control carried along for 
the  antibody  used.  Cells  were  analyzed  on  a  FacsCalibur  using  Cellquest  Pro  software  (all  Becton 
Dickinson, Heidelberg, Germany). Analysis was performed in triplicates in 2 independent experiments 
for each combination of fatty acid supplementation and stimulator. 
3.7. Statistical Analysis 
Data are shown as means ± standard deviation (SD). One-way analysis of variance and one-way 
ANOVA followed by unpaired Students t test was used to identify significant differences between 
means. The statistical analysis was carried out by means of the program GraphPad Prism 4 (GaphPad 
Software, La Jolla, CA USA). In all cases, p < 0.05 was assumed to indicate significant differences. 
4. Conclusions 
In conclusion, using RAW264.7 macrophages as a model system, we identified the unsaturated fatty 
acids  LNA,  EPA,  DHA,  LA  and  AA  to  affect  macrophage  function,  thereby  driving  the  immune 
defense in an anti-inflammatory direction. The concentration of free fatty acids tested in our system 
match physiological conditions [36] thus underlining the relevance of the results obtained. Our data 
provide first evidence that PUFA from both the n-3 and the n-6 family down-regulate the synthesis of: 
(i) the pro-inflammatory cytokines IL-1β, IL-6 and TNF-α; (ii) the co-stimulatory molecule CD86; as 
well as (iii) the antimicrobial polypeptide lysozyme. Interestingly, the action of the fatty acids partially 
depended on the activation status of the macrophages. It is particularly important to note that the 
immune-suppressive action of PUFA could also be demonstrated in case of infection of RAW264.7 
with viable microorganisms of the genera R. equi and P. aeruginosa. Taken together, our data provide 
strong evidence that n-3 as well as n-6 fatty acids level down inflammation processes in context of 
chronic infections caused by persistent pathogens. Int. J. Mol. Sci. 2011, 12                       
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